Atezolizumab vs Baricitinib

## Atezolizumab vs Baricitinib: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Baricitinib**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Baricitinib — 12 hours.

## Chemical Properties

**Molecular Formula**: Atezolizumab — N/A; Baricitinib — C16H17N7O2S.

**Molecular Weight**: Atezolizumab — N/A; Baricitinib — 371.4170 g/mol.

**Type**: Atezolizumab — Antibody; Baricitinib — Small molecule.